Page 493 - Hematology_ Basic Principles and Practice ( PDFDrive )

414 Part IV Disorders of Hematopoietic Cell Development

Morgan GJ, Alveres CL: Benzene and the hemopoietic stem cell. Chem Biol Tisdale JF, Dunn DE, Geller N, et al: High-dose cyclophosphamide in severe
Interact 30:153, 2005. aplastic anaemia: A randomised trial. Lancet 356:1554, 2000.
Rosenfeld SJ, Follman D, Nunez O, et al: Antithymocyte globulin and Yoshizato T, Dumitriu B, Hosokawa K, et al: Somatic mutations and clonal
cyclosporine for severe aplastic anemia. Association between hematologic hematopoiesis in aplastic anemia. N Engl J Med 373:35–47, 2015.
response and long-term outcome. JAMA 289:1130, 2003. Young NS, Calado R, Scheinberg P: Current concepts in the pathophysiology
Socie G, Stone JV, Wingard JR, et al: Long-term survival and late deaths after and treatment of aplastic anemia. Blood 108:2511, 2006.
allogeneic bone marrow transplantation. Late Effects Working Commit-
tee of the International Bone Marrow Transplant Registry. N Engl J Med
341:14, 1999. REFERENCES
Tichelli A, Socie G, Marsh J, et al: Outcome of pregnancy and disease course
among women with aplastic anemia treated with immunosuppression. For the complete list of references, log on to www.expertconsult.com.
Ann Intern Med 137:164, 2002.